Pages that link to "Q41978904"

The following pages link to In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. (Q41978904):

Displaying 25 items.

• Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy (Q28300540) (← links)
• Imipenem/Cilastatin (Q29400850) (← links)
• Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland (Q33289660) (← links)
• Gram positive infection in trauma patients: new strategies to decrease emerging Gram-positive resistance and vancomycin toxicity (Q34117834) (← links)
• Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus (Q35111075) (← links)
• In vitro susceptibilities of four species of coagulase-negative staphylococci (Q35575038) (← links)
• Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery (Q35645295) (← links)
• Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections (Q35648273) (← links)
• Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus (Q35759130) (← links)
• Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections (Q36718474) (← links)
• Failure of routine susceptibility tests to detect imipenem resistance among strains of methicillin-resistant Staphylococcus aureus (Q36754338) (← links)
• Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (Q38739367) (← links)
• Penems: in vitro and in vivo experiments (Q39637655) (← links)
• Vancomycin: an update (Q39746652) (← links)
• In vitro activity of imipenem--a review (Q40192467) (← links)
• Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C. (Q40218412) (← links)
• Activity of 18 antimicrobial agents against multi-resistant strains of Staphylococcus aureus isolated from intensive care patients (Q44182981) (← links)
• Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents (Q47227913) (← links)
• In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. (Q54165365) (← links)
• Lysogeny of methicillin-resistant Staphylococcus aureus and the role of prophages in transfer of conjugative and non-conjugative plasmids. (Q54287272) (← links)
• Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? (Q54418668) (← links)
• Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime (Q54487036) (← links)
• The cephalosporins (Q68213793) (← links)
• Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus (Q70030559) (← links)
• Plasmid analysis of simultaneous nosocomial outbreaks of methicillin-resistant Staphylococcus aureus (Q70157549) (← links)